About Mallinckrodt
We are Mallinckrodt Pharmaceuticals, a global specialty pharmaceutical company with a rich history spanning over 150 years. Our mission is rooted in 'Listening for needs. Delivering solutions.' We are dedicated to developing, manufacturing, and distributing innovative therapies that improve outcomes for patients with severe and critical conditions. Our journey began in 1867, and since then, we've consistently used our unique strengths, extensive experience, and deep expertise to make a positive impact on people's lives. We are driven by a commitment to address unmet patient needs and simplify complex healthcare challenges.
Our core values – Patient-Centric, Integrity, Innovative, and Collaborative – guide every aspect of our work and serve as the bedrock of our success. We invest significantly in research and development, focusing on autoimmune and rare diseases across various specialty areas, including neurology, rheumatology, nephrology, pulmonology, and ophthalmology. Additionally, we are active in immunotherapy, neonatal respiratory critical care therapies, analgesics, and gastrointestinal products. We take pride in our vertically integrated process, which allows us to control every step of product development, from raw materials to finished products, ensuring a reliable supply of high-quality medicines. We believe in operating responsibly and are committed to business ethics, integrity, compliance, and environmental stewardship. Our people around the world count on Mallinckrodt products every day, and by truly understanding their challenges, we strive to deliver patient-centric solutions that help them embrace a brighter, healthier future. We are constantly looking for new ways to innovate and collaborate to bring essential treatments to those who need them most.
FAQs
- When was Mallinckrodt founded?
- Mallinckrodt was founded in 1867.
- Who is the CEO of Mallinckrodt?
- Sigurdur (Siggi) Olafsson is the CEO.
- What industries or markets does Mallinckrodt operate in?
- Mallinckrodt operates in the following markets: Specialty Pharmaceuticals, Biotechnology, Rare Diseases, Autoimmune Diseases, Critical Care Medicine, Immunotherapy, Neonatal Care, Neurology, Rheumatology, and Pharmaceutical.
- How many employees does Mallinckrodt have?
- Mallinckrodt has 1001-5000 employees.
- Where does Mallinckrodt have employees?
- Mallinckrodt has employees in Ireland.
- Does Mallinckrodt support remote work or working from home?
- Yes, Mallinckrodt is a remote-friendly company.
- Does Mallinckrodt offer a four-day work week?
- No, Mallinckrodt does not offer a four-day work week.
- What is Mallinckrodt's tech stack?
- Mallinckrodt has 3 technologies in their tech stack.
- What is Mallinckrodt's website?
- Mallinckrodt's website is mnk.com.
